Division of Plastic and Reconstructive Surgery, University of Toronto, Toronto, Canada.
Ann Surg Oncol. 2010 Apr;17(4):1052-62. doi: 10.1245/s10434-010-0915-5. Epub 2010 Jan 27.
While advances in reconstructive surgery have facilitated limb preservation in extremity soft tissue sarcoma (ESTS), limited information exists as to the functional outcome of patients with these reconstructed extremities. The primary objective of this study is to evaluate the impact of flap reconstruction on postoperative function and health status in patients undergoing limb-salvage surgery for ESTS.
Clinical and outcome data for eligible patients were extracted from a prospectively maintained database of sarcoma patients. Four outcome measures were used to assess three domains of function (impairments, activity limitations, and participation restrictions), and health status. The effect of soft tissue reconstruction on function and health status at 1-2-year follow-up was analyzed using univariate and multivariate regression.
Two hundred and forty-seven patients met eligibility criteria, including 56 patients receiving flap reconstruction and 191 patients treated with primary closure. Patients receiving flaps had larger (9.8 versus 7.1 cm; P = 0.003), higher-grade (93% versus 72%; P = 0.001) tumors, and more frequently received radiotherapy (89% versus 72%; P = 0.007), and bone (20% versus 4%; P = 0.001) and motor nerve resection (21% versus 10%; P = 0.032). Flap reconstruction was associated with more postoperative impairments [Musculoskeletal Tumor Society (MSTS) score 30.4 versus 32.2; P = 0.004] and activity limitations [Toronto Extremity Salvage Score (TESS) score 83.3 versus 89.5; P = 0.0132] on univariate analyses, but did not significantly predict postoperative function or health status outcomes on multivariate analyses.
Flap reconstruction was not an independent predictor of function and health status outcomes in patients with ESTS. However, ESTS patients receiving flaps had other clinical features placing them at risk for worse postoperative outcomes.
尽管重建手术的进步促进了四肢软组织肉瘤(ESTS)的肢体保留,但对于接受这些重建肢体的患者的功能结果,相关信息有限。本研究的主要目的是评估皮瓣重建对 ESTS 保肢手术后患者术后功能和健康状况的影响。
从肉瘤患者的前瞻性维持数据库中提取符合条件的患者的临床和结果数据。使用四项结果测量来评估三个功能领域(损伤、活动受限和参与受限)和健康状况。使用单变量和多变量回归分析皮瓣重建对 1-2 年随访时功能和健康状况的影响。
共有 247 名患者符合入选标准,其中 56 名患者接受皮瓣重建,191 名患者接受一期闭合治疗。接受皮瓣的患者肿瘤更大(9.8 厘米比 7.1 厘米;P = 0.003),分级更高(93%比 72%;P = 0.001),更频繁地接受放疗(89%比 72%;P = 0.007),以及骨(20%比 4%;P = 0.001)和运动神经切除术(21%比 10%;P = 0.032)。皮瓣重建与更多的术后损伤[肌肉骨骼肿瘤学会(MSTS)评分 30.4 分比 32.2 分;P = 0.004]和活动受限[多伦多肢体保留评分(TESS)评分 83.3 分比 89.5 分;P = 0.0132]相关,但在多变量分析中,皮瓣重建并不是 ESTS 患者术后功能和健康状况的独立预测因素。
皮瓣重建不是 ESTS 患者功能和健康状况结果的独立预测因素。然而,接受皮瓣的 ESTS 患者有其他临床特征,使他们有术后结果更差的风险。